CVS Health Corp (CVS) Earnings Forecast: $366B Revenue by 2024, Introducing New Pharmacy Reimbursement Model

Cvs Health Corp on Smartkarma

According to research reports published by Baptista Research on Smartkarma, an independent investment research network, CVS Health Corp has exceeded analyst expectations in terms of revenue and earnings. The Pharmacy & Consumer Wellness segment achieved nearly $29 billion in revenues and the acquisitions of Signify Health and Oak Street Health have strengthened its position in value-based care. The research reports have given CVS Health Corp a ‘Buy’ rating with a revised target price.

The research reports state that CVS Health Corp has demonstrated significant progress in restoring its Medicare Advantage Star rating and efforts to connect its acquired assets with existing offerings are expected to accelerate growth. The research reports have been authored by Baptista Research and have a ‘Bull’ sentiment.

A look at Cvs Health Corp Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

CVS Health Corporation has long-term potential for investors. According to Smartkarma Smart Scores, the company scores high in value, dividend, and momentum. With a score of 4 for value, CVS Health Corporation is a great option for investors looking for a solid investment with a good return. Additionally, CVS Health Corporation has a score of 3 for dividend, making it an attractive option for investors looking for a steady income. Lastly, its score of 3 for momentum indicates that the company has a stable outlook for the future.

As a leading integrated pharmacy health care provider, CVS Health Corporation operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico. It offers a variety of services, including pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. With its strong scores for value, dividend, and momentum, CVS Health Corporation is well-positioned for long-term success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma